The two most well-covered initial public offerings of 2017 have been major flops. Snap Inc (NYSE:SNAP) went public in early March at $17. After an early pop, SNAP stock soon dipped below that level, dropping below $12 before a recent recovery.
Source: Shutterstock
Blue Apron Holdings Inc (NYSE:APRN) has performed even worse. APRN stock dipped below its $10 IPO price in just its second session — and that was after the initial range was slashed from an expected $15-$17. APRN stock has gone basically nowhere but down, losing nearly half of its value in a matter of weeks.
buy stocks online: Actinium Pharmaceuticals, Inc.(ATNM)
Advisors’ Opinion:
- [By Lisa Levin]
Shares of Actinium Pharmaceuticals Inc (NYSE: ATNM) were down 24 percent to $1.29. Actinium priced 8 million shares at $1.25 per share.
Shineco Inc (NASDAQ: TYHT) was down, falling around 32 percent to $19.50. On Wednesday, Shineco priced IPO at $4.50 per share.
buy stocks online: Emerald Health Therapeutics, Inc. (TBQBF)
Advisors’ Opinion:
- [By Javier Hasse]
Emerald Health Therapeutics Inc (OTC: TBQBF) raised C$13.8 million ($10.5 million) under a bought deal financing.
“The money will be primarily used for facility expansion."
The Green Solution received a $7.5 million loan facility from iAnthus Capital Holdings Inc (OTC: ITHUF).
buy stocks online: Equifax, Inc.(EFX)
Advisors’ Opinion:
- [By Paul Ausick]
Equifax Inc. (NYSE: EFX) posted a new 52-week low of $101.27 on Wednesday, down about 12.7% from Tuesday’s closing price of $115.96. The stock’s 52-week high is $147.02. Volume totaled around 12.6 million shares, about 12 times the daily average. The company is getting hammered following its announcement of a data breach involving records for 143 million Americans.
- [By Lee Jackson]
The top man at Equifax Inc. (NYSE: EFX) sold a big chunk of stock last week. CEO Richard Smith parted ways with 74,346 shares at prices that fell between $130.74 and $131.40. The total for the trade was set at $10 million. The stock ended the weekat $132.80. The 52-week range for the shares is $104.66 to $139.67, and the consensus price objective is $140.50.
- [By Dustin Blitchok]
And the credit reporting bureau Equifax Inc. (NYSE: EFX) announced Sept. 7 that 143 million people could potentially be affected by a breach of the most sensitive data: names, Social Security numbers, birth dates, addresses, driver’s license numbers and credit card numbers.
- [By Money Morning Staff Reports]
But the fact that the credit-reporting company Equifax Inc. (NYSE: EFX) was hacked isn’t even the most damning fact for retail investors like you and me.
- [By Paul Ausick]
If you are among the nearly half of Americans who could be affected by the data breach at Equifax Inc. (NYSE: EFX) it is important to take some action to protect yourself from what might happen next. If your personally identifiable data was stolen in the attack on Equifax, you are vulnerable to phishing attacks, unauthorized new credit card accounts, and a wrecked credit history.
buy stocks online: Syndax Pharmaceuticals, Inc. (SNDX)
Advisors’ Opinion:
- [By Lisa Levin]
Shares of Syndax Pharmaceuticals Inc (NASDAQ: SNDX) got a boost, shooting up 32 percent to $12.40 after the company reported the advancement of ENCORE 601 in non-small cell lung cancer patients with disease progression on or after PD-1 therapies.
- [By Chris Lange]
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is watching its shares make a handy gain on Wednesday after the firm reported a key agreement. Essentially, the company announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI).
